Hi Charles89,
I agree with the LFT/ART approach which will promotes results to testing being known quicker as long as there high sensitivity (which EuGeni can deliver).
With regards the 3% of people getting missed, I think it’s important to highlight that figure relates to those who are positive cases. Imo if 10,000 people attend a concert and the prevalence of COVID-19 is 2% or less within that city’s population, you could then assume that 200 people have COVID-19. If everyone is tested we could assume that the “3% of people being missed” would total 6 people out of 10,000. Of those 6 missed, some may not be infectious, all 6 may not be infectious.
I hope the example I’ve given makes sense and has some merit.
aimho
GLTAH
- Forums
- ASX - By Stock
- ADO
- Ann: Test Platform and COVID-19 Test receive CE Mark approval
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-330
-
- There are more pages in this discussion • 630 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 604706 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.019 |
18 | 2293829 | 0.018 |
6 | 2807891 | 0.017 |
5 | 1728529 | 0.016 |
8 | 1703869 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 604706 | 5 |
0.021 | 971580 | 3 |
0.022 | 281320 | 3 |
0.024 | 531781 | 3 |
0.025 | 406936 | 5 |
Last trade - 07.31am 16/08/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online